Antibiotics in periodontal therapy: advantages and disadvantages

Journal of Clinical Periodontology

Volumn 17, Issue , 1990, Pages 479-493

  Slots, Jergen ^a   Rams, Thomas E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antibiotics; periodontal pathogens; periodontal therapy

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFALEXIN; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; METRONIDAZOLE; MINOCYCLINE; PENICILLIN G; TETRACYCLINE;

CONFERENCE PAPER; HUMAN; MICROORGANISM; MOUTH FLORA; PERIODONTITIS; PRIORITY JOURNAL;

ANTIBIOTICS; BACTERIA; HUMAN; PERIODONTITIS;

EID: 0025372732     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/j.1365-2710.1992.tb01220.x     Document Type: Article

References (180)

1. Use of antimicrobial containing acrylic strips in the treatment of chronic periodontal disease. A three month follow‐up study
2. The development and clincial use of acrylic strips containing anti‐microbial agents in the management of chronic periodontitis
3. Role of displacement dressings in the resolution of chronic inflammatory periodontal disease
4. Microbiology of failing osseointegrated dental implants
5. Ciprofloxacin: an update on clinical experience
6. The efficacy of nitroimi‐dazoles at moderate or deep periodontal pockets
7. The effects of a simplified oral hygiene regimen plus supragingival irrigation with chlorhexidine or metronidazole on chronic inflammatory periodontal disease
8. Tetracycline and its derivatives strongly bind to and are released from the tooth surface in active form
9. Susceptibility of human oral anaerobic bacteria to antibiotics suitable for topical use
10. Inhibition of oral contraceptive effectiveness by concurrent antibiotic administration ‐ a review
11. Tetracycline‐impregnated enamel and dentin: duration of antimicrobial capacity
12. Clinical and microbiological study of “refractory” adult periodontitis
13. The capability oiActinoba‐cillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius to indicate progressive periodontitis; a retrospective study
14. Serum and crevicular fluid concentrations after a single oral dose of metronidazole
15. Effect of Aug‐mentin on microbiota associated with refractory periodontitis
16. Pigmentation of the jawbones and teeth secondary to minocycline hydrochloride therapy
17. Comparison of spiramycin and tetracycline used adjunc‐tively in the treatment of advanced periodontitis
18. The role of adjunctive Rodogyl therapy in the treatment of advanced periodontal disease. A ngitudinal clinical and microbiological study
19. Susceptibility of obligate amaerobes to metronidazole: an extended study of 1,054 clinical isolates
20. The effects of systemic tetracycline alone on localized juvenile periodontitis
21. Systemic antibiotic combination therapy in recalcitrant and recurrent localized juvenile periodontitis
22. Tetracyclines and periodontal therapy
23. An evaluation of minocycline in patients with periodontal disease
24. The effect of short‐term administration of minocycline HC1 on gingival inflammation and subgingival microflora
25. Effectiveness of routine periodontal treatment with and without adjunctive metronidazole therapy in a sample of mentally retarded adolescents
26. Prevention of bacterial endocarditis: a committee report of the American Heart Association
27. Pharmacokinetics and tissue penetration of ciprofloxacin
28. Multi‐center evaluation of tetracycline fiber therapy. II. Clinical responses
29. Diagnostische Mikrobiologie und parodontal Erkran‐kungen: Theorie und Praxis
30. Overview of drug interactions with the quinolones
31. Microbiology of subgingival plaque from children with localized prepubertal periodontitis
32. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases
33. Gram negative species associated with active destructive periodontal lesions
34. Infective endocarditis caused by slow‐growing, fastidous, gram‐negative bacteria
35. Failure of vancomycin prophylaxis and treatment for Actinobacil‐lus actinomycetemcomitans endocarditis
36. A clinical, demographic and microbiologic study of ANUG patients in an urban dental school
37. Recurrent periodontitis: effect of doxycycline on the subgingival microflora
38. Treatment of localized juvenile periodontitis
39. Infective endocarditis caused by Actinobacillus actinomycetemcomitans, report of four cases
40. Effects of short‐term administration of metronidazole on the subgingival microflora
41. Clindamy‐cin‐associated pseudomembranous colitis: a potentially fatal adverse drug reaction
42. Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease
43. Comparative response of mobile teeth following monolithic fiber therapy or scaling
44. Clinical response following periodontal treatment by local drug delivery
45. Periodontal disease treatment by local drug delivery
46. Concentration of tetracycline in human gingival fluid after single doses
47. Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses
48. Efficacy of clindamycin hydrochloride in refractory periodontitis ‐ 12‐month results
49. Treatment of juvenile periodontitis with subgingival tetracycline fibers or flap surgery
50. Combined antibiotic (metronidazole) and mechanical treatment effects on the subgingival bacterial flora of sites with recurrent periodontal disease
51. Effect of modified Widman flap surgery and systemic tetracycline on the subgingival microbiota of periodontal lesions
52. Clinical, microbiological and immunological features of subjects with destructive periodontal diseases
53. Bacteriology and serology of the periodontal abscess
54. Periodontosis. Part III. Barbados study
55. Effects of tetracycline on the streptococcal flora of periodontal pockets
56. Tetracycline‐loaded monolithic fibers: a four‐quadrant comparative study of efficacy in periodontal therapy
57. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man
58. Antibiotic resistance of oral bacteria before and after administration of systemic tetracycline
59. The effect of tetracycline and/ or scaling on human periodontal disease
60. Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans
61. Clinical responses to tetracycline fibers combined with scaling
62. An evaluation of two antibacterial agents in the management of rapidly progressive periodontitis
63. Activity of metronidazole and its hydroxy metabolic against clinical isolates of Actinobacillus actinomycetemcomitans
64. Effect of metronidazole on chronic periodontal disease in subjects using a topically applied chlorhexidine gel
65. A follow‐up study 3 years after metronidazole therapy for chronic periodontal disease
66. Penicillin resistance in the subgingival microbiota associated with adult periodontitis
67. The effect of long‐term low‐dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis
68. Treatment of refractory periodontitis with metronidazole plus amoxicillin or Aug‐mentin
69. Clinical and microbiological evaluation of therapy for juvenile periodontitis
70. A clinical trial of phenoxymethyl penicillin for adjunctive treatment of juvenile periodontitis
71. The effect of subminimal inhibitory concentrations of antimicrobial agents on three bacterial mixtures
72. Bacteroides forsythus in adult gingivitis and periodontitis
73. Subinhibitory concentration of tetracycline alter fibrinogen binding by Bacteroides intermedius
74. Clinical and microbiologic changes following subgingival irrigation with metronidazole or stannous fluoride
75. Gingival fluid levels of amoxicillin and its MICs for periodontal bacteria
76. Treatment of localized juvenile periodontitis
77. Local tetracycline delivery using hollow fiber devices in periodontal therapy
78. Treatment of localized juvenile periodontitis. Results after 5 years
79. Effect of long‐term tetracycline therapy on human periodontal disease
80. Use of metronidazole as a probe in the study of human periodontal disease
81. Pathogenesis of periodontitis
82. A perspective on periodontal diagnosis
83. Effect of tetracycline and/or scaling on human periodontal disease. Clinical, microbiological, and histopathological observations
84. Chemotherapy of dental plaque infections
85. Metronidazole therapy for periodontitis
86. The bacteriology of acute necrotizing ulcerative gingivitis
87. Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks
88. Treatment of periodontal infections due to anaerobic bacteria with short‐term treatment with metronidazole
89. Bacterial profiles of subgingival plaques in periodontitis
90. Changes in attachment level in subjects with progressive “refractory” periodontitis
91. Effect of combined systemic antimicrobial therapy and mechanical plaque control in patients with recurrent periodontal disease
92. Antimicrobial irrigation of deep pockets to supplement oral hygiene instruction and root debridement. I. Biweekly irrigation
93. The value of systemically administered metronidazole in the modified Widman flap procedure
94. A longitudinal microbiological investigation of Actinobacillus actinomycetemcomitans and Eikenella cor‐rodens in juvenile periodontitis
95. Clinical, immunologic and microbiologic features of active disease sites in juvenile periodontitis
96. Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis
97. The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis
98. The periodontal microflora of juvenile diabetics. Culture, immunofluorescence, and serum antibody studies
99. Efficacy of doxycycline in prevention of recurrent periodontitis
100. Clinical evaluation of spiramycin and erythromycin in control of periodontal disease
101. Clincial effects of local application of collagen film‐immobilized tetracycline
102. Pseudotumor cerebi, a rare adverse reaction to tetracycline therapy: a case report
103. Effect of topically applied tetracycline on microflora of juvenile periodontitis
104. Metronidazole: its use in clinical dentistry
105. Bacterial endocarditis due to an actinobacillus
106. In vitro antibacterial activity of ofloxacin against periodontal disease‐associated bacteria
107. Treatment of recurrent periodontal disease by root planning and ornidazole (Tiberal). Clinical and microbiological findings
108. The microbiota associated with successful or failing osseointegrated titanium implants
109. Microbiology of HIV‐associated gingivitis and periodontitis
110. Intraoral fixed drug eruption following tetracycline administration
111. Serological studies of oral Bacteroides intermedius
112. Slow release metronidazole and a simplified mechanical oral hygiene regimen in the control of chronic periodontitis
113. Treatment of refractory periodontitis with Augmentin
114. Periodontal treatment by local drug delivery using resorbable base material
115. Tetracycline therapy in patients with early juvenile periodontitis
116. Microbiological and clinical effects of systemic antibiotic administration in advanced periodontitis
117. Refractory chronic periodontitis: effect of oral tetracycline hydrochloride and root planing
118. Gingival crevicular fluid levels of erythromycin and the in vitro effect on periodontal bacteria
119. Concentration of doxycycline in human gingival fluid
120. Alteration of fimbriation and cell hydrophobicity by sublethal concentration of tetracycline
121. Microbiology of acute periodontal infection in myelosup‐pressed cancer patients
122. Mino‐cycline‐associated tooth discoloration in young adults
123. Topical treatment of adult periodontitis with tetra‐cycline‐HCl
124. Topical application of tetracycline‐HCl in human periodontitis
125. Availability of laboratory testing services for identification of periodontal pathogens in dental plaque
126. Subgingival microbial flora of HIV‐related periodontitis
127. A rational for the management of periodontal diseases: effects of tetracycline on subgingival bacteria
128. Long‐term effects of microbiologically modulated periodontal therapy on advanced adult periodontitis
129. The subgingival microbial flora associated with human dental implants
130. On the inability of root debridement and periodontal surgery to eliminate Actinobacillus actinomycetemcomitans from periodontal pockets
131. Periodontal disease and oral microbial successions during myelosuppressive cancer chemotherapy
132. Safety of nitroimidazoles
133. The subgingival microflora following root planing with or without local tetracycline application
134. Ciprofloxacin: in vitro activity, mechanism of action, and resistance
135. Antibiotic administration and oral contraceptive failure. A drug interaction to note
136. Distribution of certain subgingival microbial species in selected periodontal conditions
137. Tetracycline: a clinical study to determine its effectiveness as long‐term adjuvant
138. Endocarditis caused by Actinobacillus actinomycetemcomitans
139. Clinical and microbiologic effects of local tetracycline irrigation on periodontitis
140. Rapid identification of important periodontal microorganisms by cultivation
141. Bacterial specificity in adult periodontitis. A summary of recent work
142. Relationship between some subgingival bacteria and periodontal pocket depth and gain or loss of periodontal attachment after treatment of adult periodontitis
143. In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans
144. Epidemiology of Actinobacillus actinomycetemcomitans and Bacteroides intermedius in human periodontitis
145. Black‐pig‐mented Bacteroides species, Capnocytopha‐ga species and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction
146. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases
147. Periodontal therapy in human. I Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy
148. Yeasts, enteric rods and pseudo‐monads in the subgingival flora of severe adult periodontitis
149. Actinobacillus actinomycetemcomitans in human periodontal disease: a cross‐sectional microbiological investigation
150. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline
151. Suppression of penicillin‐resistant oral Actinobacillus actinomycetemcomitans with tetracycline. Considerations in endocarditis prophylaxis
152. The effect of metronidazole in treatment of young adults with severe periodontitis
153. Effects of minocycline on fibroblast attachment and spreading
154. Metronidazole as an adjunct to periodontal therapy with subgingival curettage
155. Antimicrobial susceptibilities of bacteria associated with periodontal disease
156. Prevalence and microbiology of localized prepubertal periodontitis
157. Effect of spiramycin therapy on human periodontal disease
158. Wolinella recta, Campylobacter concisus, Bacteroides gracilis, and Eikenella corrodens from periodontal lesions
159. A biochemical approach to periodontal regeneration: tetracycline treatment of dentin promotes fibroblast adhesion and growth
160. New concepts in the treatment of periodontitis
161. Microbial and clinical measurements of periodontal pockets during sequential periods of non‐treatment, mechanical debridement and metronidazole therapy
162. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose
163. Metronidazole plus amoxicillin in the treatment of Actinobacil‐lus actinomycetemcomitans associated periodontitis
164. Gingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentrations for periodontal bacteria
165. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents
166. Penicillin‐degrading enzymes in sites associated with adult periodontitis
167. Clinical and microbiological effects of single‐dose metronidazole or scaling and root planing in the tieaiment of adult periodontitis
168. Subgingival metronidazole in dialysis tubing and subgingival chlorhexidine irrigation in the control of chronic inflammatory periodontal disease
169. Clinical and in vitro studies of the bactericidal activity of metronidazole against anaerobic bacteria
170. Metronidazole: a double‐blind trial in untreated human periodontal disease
171. Toothbrush‐ing with hydrogen peroxide‐sodium bicarbonate compared to toothpowder and water in reducing periodontal pockets suppuration and darkfield bacterial counts
172. Occurrence of resistant bacteria after doxycy‐cline therapy of marginal periodontitis
173. A biochemical approach to periodontal regeneration: tetracycline treatment conditions dentin surfaces
174. Subgingival microflora of periodontal patients on tetracycline therapy
175. Subgingival metronidazole in acrylic vs. chlorhexidine irrigation in the control of chronic periodontitis
176. Microbiological and immunological studies of adult periodontitis in patients with noninsulin‐dependent diabetes mellitus